Azoospermia treatment

Non Obstructive Azoospermia Success Stories (2024)

27 DEC 2024

We are thrilled to share an inspiring success story of a 31-year-old patient with non-obstructive azoospermia. Despite having normal hormone levels, his 2022 microTESE biopsy revealed a complete maturation arrest at the spermatocyte stage, leaving him with little hope of natural sperm production.

Determined to try every possibility, he embarked on a six-month journey with Prolistem, and the results were extraordinary! Post-treatment, he discovered approximately 200,000 sperm—a groundbreaking achievement for such a condition.

This incredible outcome is a beacon of hope, motivating us and countless others to explore the potential of Prolistem in restoring fertility for men facing similar challenges. Join the journey to redefine possibilities with Prolistem!

15 DEC 2024

Prolistem Success Story from Jordan – Irbid

A big thank you to Dr. Tawfiq Al-Far and Dr. Muhannad Al-Omari for sharing this remarkable case:

A 25-year-old patient with FSH levels of 24.5 IU/L and LH levels of 9.80 IU/L underwent six months of Prolistem treatment. Post-treatment, sperm was detected in the semen, measuring 0.3 sperm/ml, with a total count of approximately 1 million sperm in the ejaculate.

This is a significant success! The sperm was successfully frozen for future use.

11 DEC 2024

Prolistem Treatment Success Story From Dr. Hisham Abu Taha – Jordan

We are thrilled to share an inspiring success story from one of our patients, who kindly allowed us to share his journey.

This 38-year-old patient started Prolistem treatment with the following initial hormonal profile:

FSH: 28.59 mIU/ml
LH: 14.54 mIU/ml
Testosterone: 4.23 ng/ml

At the beginning of the treatment, his semen analysis revealed only two immotile sperm, making natural conception seem nearly impossible.

After just four months on Prolistem, the patient’s wife conceived—a remarkable milestone. Unfortunately, the pregnancy ended in miscarriage. While this was a difficult moment, it underscored that Prolistem had successfully stimulated sperm production and improved his fertility potential.

By the sixth month, a follow-up semen analysis showed a significant improvement, with a sperm count of 2 million motile sperm in the semen.

We are encouraged by these results and extend our heartfelt wishes to the patient and his family for continued success on their fertility journey. Stories like these remind us of the impact Prolistem can have on lives, and we are committed to helping more families achieve their dreams.

1 DEC 2024

Turning Hope into Reality: A Prolistem Success Story

A 34-year-old male with primary infertility faced numerous challenges, including high FSH (25 mIU/mL), and a 2021 biopsy showing no spermatozoa (Sertoli Cell-Only Syndrome).

After a six-month course of Prolistem, a repeat biopsy revealed the presence of sperm, opening the door to assisted reproduction.

This breakthrough highlights the transformative potential of Prolistem, giving hope where none seemed possible.

22 NOV 2024

Prolistem continues to bring joy to couples, helping improve sperm counts from zero to approximately 12 million.

A success story proudly shared by our Turkish distributor.

16 SEP 2024

A 33-year-old patient underwent a biopsy in 2022, which revealed maturation arrest at the primary spermatocyte stage. After six months of using Prolistem, a semen analysis showed the presence of 40,000 sperm.

27 AUG 2024

Prolistem Success Case

Patient Age: 26

Initial Condition: Previous biopsy failed to find sperm.

Hormones Before Prolistem:

– FSH: 28

– LH: 14

– Testosterone: 6.7

Hormones After Prolistem:

– FSH: 17.8

– LH: 8

– Testosterone: 1.1

Outcome: MicroTESE on 18/8/2024 yielded very high-quality sperm.

16 AUG 2024

A patient had previously undergone several FNAs, occasionally yielding sperm, but without success in IVF. After six months of Prolistem treatment, another FNA was performed, revealing high-quality sperm, which was then used successfully for IVF. The patient’s wife is now pregnant, and we wish them a smooth delivery.

Hormone levels before treatment were normal: FSH 3.76, LH 7.46, and testosterone 7.19.

9 AUG 2024

Prolistem is the only treatment specifically designed for azoospermia, and it’s inspiring to hear success stories, even when they come to us by chance. Every time we learn that Prolistem has helped another couple, it brings motivation and hope to those on their journey to parenthood.

31 JULY 2024

A 25-year-old patient, married for 4 years, previously underwent microTESE which revealed maturation arrest. After using Prolistem for 6 months, sperm was successfully found through a second microTESE.

Hormone Levels:

– Before Prolistem: FSH 5.3, LH 2.3, Testosterone 4.1

– After Prolistem: FSH 5.8, LH 6.6, Testosterone 7.7

21 JULY 2024

Prolistem success story: Presence of sperm in semen after Prolistem treatment for non-obstructive azoospermia, with hormone levels: FSH 2.02 mIU/ml, LH 1.41 mIU/ml, and testosterone 2.12 ng/ml

12 JULY 2024

Unbelievable results: From Sertoli cell-only syndrome to 1 million sperm in semen after six months of Prolistem treatment. This great success reaffirms that Prolistem is the true solution for overcoming azoospermia and achieving happiness.

29 JUNE 2024

A patient whose azoospermia was caused by chemotherapy experienced remarkable success with Prolistem. Before starting Prolistem, his hormone levels were as follows: FSH at 17.9 mIU/ml, LH at 14.5 mIU/ml, and testosterone at 379 ng/dl.

‏Through the microTESE procedure, sperm were successfully found and frozen for future use. This marks a significant achievement in his fertility journey

27 JUNE 2024

Prolistem Success: After six months of Prolistem treatment, 1.5 million sperm were found in the semen.

Pre-treatment hormone levels were not available, and a previous biopsy indicated maturation arrest at the spermatid level. Post-treatment hormone levels are as follows: FSH 17.3 mIU/mL, LH 6.050 mIU/mL, and testosterone 6.8 mg/mL.

This is excellent news for our patients.

25 JUNE 2024

Success with Prolistem: A patient with two previous FNAs and one microTESE, FSH 14.45, LH 7, and testosterone 175, found 2 sperm in semen after stage two (3 months). There is hope to find more after completing stage three.

10 JUNE 2024

Prolistem Success Story:

After five months of Prolistem treatment, the total sperm count in the semen reached 10.2 million.

Prolistem isn’t about lifestyle, diet, or vitamins—it’s a scientifically proven solution that works

31 MAY 2024

When traditional treatments fail to address oligospermia, consider taking Prolistem for six months. This patient initially had 2 million sperm/ml with 2% normal morphology. After using Prolistem, his sperm count increased to 37 million/ml, with 22% normal morphology. This represents a significant improvement. Good luck!

14 MAY 2024

Prolistem helped a 24-year-old.

The reason for azoospermia was an undescended testicle.

Before using Prolistem, his hormone levels were FSH 27 and testosterone 10.

Before microTESE a semen test was performed and showed 80,000 sperm, which were collected and frozen.

4 MAY 2024

Success story with Prolistem: Despite two failed microTESE procedures, this patient saw significant improvements. Before treatment, the FSH level was 48 mIU/mL, which decreased to 40 mIU/mL post-treatment, while LH remained stable around 18 mIU/mL. After six months of using Prolistem, the sperm count in semen increased to 240,000 for the first time ever, although with zero motility. This marks a remarkable improvement following the two failed microTESE attempts. We extend our best wishes for continued success to the patient.”

29 APRIL 2024

Prolistem stands as the sole treatment tailored for azoospermia, ensuring effectiveness.

Post Prolistem treatment, semen analysis reveals 12 million sperm count per mL, alongside the following hormone levels:

– FSH: 25.9 mIU/mL

– LH: 7.90 mIU/mL

– Testosterone: 4.76 ng/ml

20 APRIL 2024

After undergoing Prolistem treatment for azoospermia, there was a notable emergence of sperm in the semen. Hormone levels before the treatment were:

– FSH: 17.16

– LH: 11.55

– Testosterone: 416

However, hormone levels after the treatment were not provided.

8 MARCH 2024

Incredible Progress: After six months of Prolistem treatment, discovering a few hundred sperm in semen

Case details:

No biopsy

FSH levels at 5.46 mUI/mL testosterone at 21.39 nmol/L

Another story highlights the positive impact of Prolistem on male with non obstructive azoospermia.

27 FEB 2024

Prolistem Success Report:

Reason: undescended testis Patient, age 32

Pre-Prolistem: FSH 59 mIU/mL

Post-Prolistem: FSH 38 mIU/mL, Results: Sperm successfully retrieved by MicroTESE

26 FEB 2024

Prolistem Success Report Update:

Overcoming undescended testis challenges! Patient, aged 25, had undescended testis fixed during childhood. FNA four years ago revealed zero sperm. Pre-Prolistem: FSH 12 mIU/mL, Testosterone 9 nmol/L. Post-Prolistem: FSH 9 mIU/mL, Testosterone 4.5 nmol/L. Remarkably, MicroTESE became successful after Prolistem intervention. A testament to hope an

25 FEB 2024

Prolistem Success Story: Non-obstructive azoospermia transformed! Prior to Prolistem, high FSH and LH with low testosterone (based on patient memory). Post-Prolistem, FSH 21mIU/mL, LH 12mIU/mL, and Testosterone 1500 ng/dl. Initial semen analysis revealed a few sperm, prompting the patient to consider additional rounds of stage three and frequent semen tests.

14 FEB 2024

Exciting news! After 17 years of marriage with AZFc and previous treatments not working (microTESE), finding sperm in the semen challenges the idea that azoospermia is impossible to treat.

Prolistem’s approval shows once again how science can make a difference.

9 FEB 2024

Every day, people worldwide find success with Prolistem for Azoospermia.

We trust in science and the strength of knowledge.

Take your next step to address Azoospermia with Prolistem.

8 FEB 2024

Celebrating another success story! One of our patients diagnosed with Azoospermia took Prolistem for six months and experienced positive results.

12 JAN 2024

Prolistem success case:

Diagnosis: Non obstructive Azoospermia

Azoospermia type: Primary testicular failure

Hormones before Prolistem:

FSH level: 27.7 mIU/ml

LH level: 10.1 mIU/ml

Testosterone: 9.52 nmol/L

Previous microTESE showed Sertoli cell only.

Successfully found few sperm by the second microTESE.

10 JAN 2024

Patient details before the treatment:

Age: 40 years

FSH: 2.63 mIU/ml

LH: 2.06 mIU/ml

Testosterone: 14.15 nmol/l

No genetic issues

This patient underwent a TESE in the past with no sperm found. After using Prolistem, they found 5 sperm in semen after stage two and a few more after stage three. Discovering sperm in semen is a positive indication of improvement. Now, determining the optimal timing for sperm in semen is crucial to avoid the need for repeating a biopsy in men with azoospermia.

Therefore, we recommend men after the treatment to undergo more frequent semen analyses, even every two weeks if possible.

Non Obstructive Azoospermia Success Stories (2024)

PROLISTEM

PROLISTEM